par Piccart-Gebhart, Martine ;Di Leo, Angelo ;Hamilton, Andrew
Référence European journal of cancer, 36, 14, page (1755-1761)
Publication Publié, 2000-09
Article révisé par les pairs
Titre:
  • HER2: a 'predictive factor' ready to use in the daily management of breast cancer patients?
Auteur:Piccart-Gebhart, Martine; Di Leo, Angelo; Hamilton, Andrew
Informations sur la publication:European journal of cancer, 36, 14, page (1755-1761)
Statut de publication:Publié, 2000-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Anthracyclines -- therapeutic use
Antineoplastic Agents, Hormonal -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- diagnosis
Breast Neoplasms -- metabolism
Breast Neoplasms -- therapy
Chemotherapy, Adjuvant
Cisplatin -- administration & dosage
Drug Resistance, Neoplasm
Female
Fluorouracil -- administration & dosage
Humans
Methotrexate -- administration & dosage
Predictive Value of Tests
Receptor, erbB-2 -- metabolism
Tamoxifen -- therapeutic use
Tumor Markers, Biological -- metabolism
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/S0959-8049(00)00162-3
info:pii/S0959-8049(00)00162-3
info:scp/0033888520
info:pmid/10974622
VX-005572